Does Eli Lilly's New $5 Billion Drug Manufacturing Facility Make It a Long-Term Buy?

Key Points The facility will be located in Virginia. It is one of four state-of-the-art factories planned by the pharmaceutical giant. 10 stocks we like better than Eli Lilly › Eli Lilly (NYSE: LLY) is a pharmaceutical manufacturer, not a construction business. And yet construction has been a focal point of late, given that it's planning a set of new factories. It's devoting $5 billion or so to the first one, a big investment even for such a large company. Let's take a brief look at this venture an ...